← 返回

鼻咽癌中记忆 B 细胞与肿瘤细胞之间的细胞信号串扰不容忽视:它们参与肿瘤进展和治疗策略的意义重大

英文原题:The cellular signaling crosstalk between memory B cells and tumor cells in nasopharyngeal carcinoma cannot be overlooked: Their involvement in tumor progression and treatment strategy is significant.

查看英文原题

The cellular signaling crosstalk between memory B cells and tumor cells in nasopharyngeal carcinoma cannot be overlooked: Their involvement in tumor progression and treatment strategy is significant.

PubMed 2025/01/01(内容时间) J Cancer Q2 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

鼻咽癌(NPC)是指发生在鼻咽腔顶壁和侧壁的恶性肿瘤。通常,患者确诊时疾病往往已进展显著,而晚期NPC患者对靶向治疗的缓解率和总体临床生存预后往往不佳。包括髓源性抑制细胞和PD-L1等因子在内的多种分子机制已被探索用于改善NPC的结局。然而,在早期识别症状、精准预测癌症复发和扩散的可能性以及制定有效的治疗策略方面,仍存在挑战需要解决。B细胞的激活及其相应通路具有开发增强免疫治疗策略的潜力。然而,关于B细胞与NPC肿瘤细胞之间复杂关联的全面理解仍不完整。因此,本研究采用单细胞多组学分析来探究人NPC中与B细胞亚群相关的分子生物标志物和预后因素,同时研究其潜在机制。

基因表达综合数据库提供了来自确诊NPC患者的肿瘤和血液样本。随后,我们分析了这些单细胞数据。在评估NPC样本质量后,我们采用R包“Harmony”利用PCA结果来减轻批次差异。采用基因本体论、基因集富集分析和京都基因与基因组百科全书分析来检查NPC肿瘤B细胞亚群中的差异表达基因。采用Monocle和Slingshot软件工具研究了NPC中B细胞的伪时间轨迹。此外,利用CellChat包预测了不同B细胞亚群与癌细胞之间细胞间通讯的发生率。进一步,我们利用单因素Cox回归、LASSO和多因素Cox回归分析构建了预后模型。使用ESTIMATE、CIBERSORT和xCell评估了肿瘤组织中的免疫细胞浸润。此外,采用infercnv评估了NPC细胞中拷贝数变异的程度。为了预测特定肿瘤样本对化疗的潜在反应,使用了名为'pRRophetic'的R包。

单细胞RNA测序有效识别了NPC中的多种细胞亚群,包括T/NK细胞、B细胞、浆细胞、髓系细胞、肥大细胞和恶性细胞。对B细胞亚群的全面检查显示其分为13个不同的组,每组具有独特的特征和功能。富集分析表明,C4 CD86+ Memory B细胞可能在抑制病毒入侵和活动方面发挥作用。通过轨迹分析,我们绘制了B细胞的分化路径,并发现C4 CD86+ Memory B细胞代表该分化过程的最终阶段。此外,信号通讯分析显示,C4 CD86+ Memory B细胞有可能通过CD99-CD99、SEMA4-PLXNB2以及特别是CD46-JAG1信号通路与恶性细胞启动相互作用。为了构建CD86+ Memory B评分,我们采用单因素Cox回归分析、LASSO回归分析和多因素Cox回归分析,基于C4 CD86+ Memory B细胞的前100个标记基因筛选出14个基因。

结果表明,C4 CD86+ Memory B细胞可能对NPC中的病毒活性具有抑制作用。然而,CD86+Memory B评分较高亚组的患者表现出更差的预后。这可能归因于C4 CD86+ Memory B细胞通过CD46-JAG1信号通路在肿瘤细胞增殖和分化中发挥关键作用。d

展开英文摘要原文

Background: Nasopharyngeal carcinoma (NPC) refers to a cancerous tumor that develops in the upper and side walls of the nasopharyngeal cavity. Typically, individuals are often diagnosed with the disease when it has already progressed significantly, and those with advanced NPC tend to have an unfavorable outlook in terms of response rate to targeted treatments and overall clinical survival. Various molecular mechanisms, including Myeloid-derived suppressor cells and factors like PD-L1, have been explored to enhance the outcome of NPC.

However, there are still challenges to be addressed in terms of identifying symptoms at an early stage, making precise predictions about the chances of cancer returning and spreading, and devising successful approaches for treatment. The activation of B cells and their corresponding pathways holds potential for developing enhanced immune therapeutic strategies. Nevertheless, the comprehensive understanding of the intricate association between B cells and NPC tumor cells remains incomplete. Hence, this study employed single-cell multi-omics analysis to investigate the molecular biomarkers and prognostic factors linked to B cell subpopulations in human NPC while examining the underlying mechanisms.

Materials and Methods: The Gene Expression Omnibus database provided tumor and blood samples obtained from patients diagnosed with NPC. Subsequently, we analyzed these single-cell data. Following the assessment of NPC sample quality, we employed the R package 'Harmony' to mitigate batch discrepancies using PCA outcomes.

The analysis of Gene Ontology, Gene Set Enrichment Analysis, and Kyoto Encyclopedia of Genes and Genomes was used to examine differentially expressed genes in B cell subpopulations of NPC tumors. The pseudo-temporal trajectories of B cells in NPC were studied using the Monocle and Slingshot software tools.

In addition, the CellChat package was utilized to predict the incidence of intercellular communication between different subpopulations of B cells and cancerous cells.

Furthermore, we utilized univariate Cox regression, LASSO, and multivariate Cox regression analysis to construct prognostic models. The immune cell infiltration was evaluated in tumor tissues using ESTIMATE, CIBERSORT, and xCell.

Furthermore, the infercnv was employed to assess the extent of copy number variation in NPC cells. To forecast the potential reaction of particular tumor samples to chemotherapy, the R package called 'pRRophetic' was utilized. Results: Single-cell RNA sequencing effectively identified various cell subgroups in NPC, including T/NK cells, B cells, plasma cells, myeloid cells, mast cells, and malignant cells.

A comprehensive examination of the B cell subgroups revealed their division into 13 distinct groups, each with unique characteristics and functions. Enrichment analysis indicated that C4 CD86+ Memory B cells may play a role in inhibiting viral invasion and activity. Through trajectory analysis, we mapped the differentiation pathways of B cells and found that C4 CD86+ Memory B cells represent the final stage of this differentiation process.

Furthermore, signal communication analysis revealed that C4 CD86+ Memory B cells have the potential to initiate interactions with malignant cells via the CD99-CD99, SEMA4-PLXNB2, and notably the CD46-JAG1 signaling pathways.

To construct the CD86+ Memory B score, we employed univariate Cox regression analysis, LASSO regression analysis, and multivariate Cox regression analysis to screen 14 genes based on the top 100 marker genes of C4 CD86+ Memory B cells. Conclusion: The results indicate that the C4 CD86+ Memory B cells may have a suppressive impact on viral activity in NPC.

However, patients with a higher subgroup of CD86+Memory B scores exhibited a worse prognosis. This could be attributed to the crucial involvement of C4 CD86+ Memory B cells in the proliferation and differentiation of tumor cells, which occurs through the CD46-JAG1 signaling pathway. The d

论文信息

作者
Li H、Bian Y、Xiahou Z、Zhao Z、Zhao F、Zhang Q
第一作者单位
Department of Clinical Laboratory, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.China
通讯作者单位
Department of Otolaryngology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.China
期刊
Journal of Cancer2025
原文标识
PubMed 39744570 · DOI 10.7150/jca.101420